139 related articles for article (PubMed ID: 37909437)
21. Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Br J Cancer; 2008 Feb; 98(4):845-51. PubMed ID: 18231102
[TBL] [Abstract][Full Text] [Related]
22. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.
Kertesz N; Krasnoperov V; Reddy R; Leshanski L; Kumar SR; Zozulya S; Gill PS
Blood; 2006 Mar; 107(6):2330-8. PubMed ID: 16322467
[TBL] [Abstract][Full Text] [Related]
23. Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension.
Crnkovic S; Rittchen S; Jandl K; Gindlhuber J; Zabini D; Mutgan AC; Valzano F; Boehm PM; Hoetzenecker K; Toller W; Veith C; Heinemann A; Schermuly RT; Olschewski A; Marsh LM; Kwapiszewska G
Hypertension; 2023 Feb; 80(2):e17-e28. PubMed ID: 36519465
[TBL] [Abstract][Full Text] [Related]
24. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
[TBL] [Abstract][Full Text] [Related]
25. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
Bai J; Wang YJ; Liu L; Zhao YL
J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
[TBL] [Abstract][Full Text] [Related]
26. The differential expression of EPHB4 and ephrin B2 in cutaneous squamous cell carcinoma according to the grade of tumor differentiation: a clinicopathological study.
Oh ST; Yang KJ; Bae JM; Park HJ; Yoo DS; Park YM
Int J Dermatol; 2021 Jun; 60(6):736-741. PubMed ID: 33598934
[TBL] [Abstract][Full Text] [Related]
27. EphB4 signaling is capable of mediating ephrinB2-induced inhibition of cell migration.
Sturz A; Bader B; Thierauch KH; Glienke J
Biochem Biophys Res Commun; 2004 Jan; 313(1):80-8. PubMed ID: 14672701
[TBL] [Abstract][Full Text] [Related]
28. Communication between ephrinB2 and EphB4 within the osteoblast lineage.
Martin TJ; Allan EH; Ho PW; Gooi JH; Quinn JM; Gillespie MT; Krasnoperov V; Sims NA
Adv Exp Med Biol; 2010; 658():51-60. PubMed ID: 19950015
[TBL] [Abstract][Full Text] [Related]
29. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.
Kumar SR; Singh J; Xia G; Krasnoperov V; Hassanieh L; Ley EJ; Scehnet J; Kumar NG; Hawes D; Press MF; Weaver FA; Gill PS
Am J Pathol; 2006 Jul; 169(1):279-93. PubMed ID: 16816380
[TBL] [Abstract][Full Text] [Related]
30. EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.
Nguyen TM; Arthur A; Hayball JD; Gronthos S
Stem Cells Dev; 2013 Oct; 22(20):2751-64. PubMed ID: 23711177
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.
Helbling PM; Saulnier DM; Robinson V; Christiansen JH; Wilkinson DG; Brändli AW
Dev Dyn; 1999 Dec; 216(4-5):361-73. PubMed ID: 10633856
[TBL] [Abstract][Full Text] [Related]
32. Spatiomechanical Modulation of EphB4-Ephrin-B2 Signaling in Neural Stem Cell Differentiation.
Dong M; Spelke DP; Lee YK; Chung JK; Yu CH; Schaffer DV; Groves JT
Biophys J; 2018 Sep; 115(5):865-873. PubMed ID: 30075851
[TBL] [Abstract][Full Text] [Related]
33. EphB4 forward signalling regulates lymphatic valve development.
Zhang G; Brady J; Liang WC; Wu Y; Henkemeyer M; Yan M
Nat Commun; 2015 Apr; 6():6625. PubMed ID: 25865237
[TBL] [Abstract][Full Text] [Related]
34. Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.
Das A; Shergill U; Thakur L; Sinha S; Urrutia R; Mukhopadhyay D; Shah VH
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G908-15. PubMed ID: 20338920
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers.
Bhatia S; Oweida A; Lennon S; Darragh LB; Milner D; Phan AV; Mueller AC; Van Court B; Raben D; Serkova NJ; Wang XJ; Jimeno A; Clambey ET; Pasquale EB; Karam SD
Cancer Res; 2019 May; 79(10):2722-2735. PubMed ID: 30894369
[TBL] [Abstract][Full Text] [Related]
36. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis.
Helbling PM; Saulnier DM; Brändli AW
Development; 2000 Jan; 127(2):269-78. PubMed ID: 10603345
[TBL] [Abstract][Full Text] [Related]
37. EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity.
Frye M; Stritt S; Ortsäter H; Hernandez Vasquez M; Kaakinen M; Vicente A; Wiseman J; Eklund L; Martínez-Torrecuadrada JL; Vestweber D; Mäkinen T
Elife; 2020 Sep; 9():. PubMed ID: 32897857
[TBL] [Abstract][Full Text] [Related]
38. EphB4 forward-signaling regulates cardiac progenitor development in mouse ES cells.
Chen K; Bai H; Liu Y; Hoyle DL; Shen WF; Wu LQ; Wang ZZ
J Cell Biochem; 2015 Mar; 116(3):467-75. PubMed ID: 25359705
[TBL] [Abstract][Full Text] [Related]
39. Porphyromonas gingivalis lipopolysaccharide regulates ephrin/Eph signalling in human periodontal ligament fibroblasts.
Li M; Zhang C; Jin L; Matsuo K; Yang Y
J Periodontal Res; 2017 Oct; 52(5):913-921. PubMed ID: 28590061
[TBL] [Abstract][Full Text] [Related]
40. The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
Du E; Li X; He S; Li X; He S
Mol Biol Rep; 2020 Jun; 47(6):4681-4690. PubMed ID: 32488576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
